N-terminal pro-brain natriuretic peptide: A powerful predictor of mortality in hypertension

Hypertension

Volumn 57, Issue 4, 2011, Pages 702-709

  Paget, Vinciane ^a   Legedz, Liliana ^a,b,c,d   Gaudebout, Nathalie ^a   Girerd, Nicolas ^a   Bricca, Giampiero ^b,c,d   Milon, Hugues ^c,d   Vincent, Madeleine ^b   Lantelme, Pierre ^a,b,c,d  

^a European Society of Hypertension Excellence Center   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

^d INSERM   (France)

Author keywords

hypertension; left ventricular hypertrophy; NT proBNP; risk stratification; survival

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; R WAVE;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE MONITORING, AMBULATORY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SURVIVAL RATE;

EID: 79953198915     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.163550     Document Type: Article

References (35)

1. Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A. 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens. 2007;25:1751-1762.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566. (Pubitemid 20176696)
3. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000;35:580-586. (Pubitemid 30108152)
4. Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med. 2004;117:14-18. (Pubitemid 38798016)
5. Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Zanchetti A. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives. J Hypertens. 2006;24:1671-1677. (Pubitemid 44162471)
6. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H. Human brain natriuretic peptide, a novel cardiac hormone. Lancet. 1990;335:801-802. (Pubitemid 20106739)
7. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625.
8. Farmakis D, Filippatos G, Tubaro M, Peacock WF, Disomma S, Mueller C, Kremastinos DT, Maisel AS. Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications. Congest Heart Fail. 2008;14:25-29.
9. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension. 1996;28:22-30. (Pubitemid 26231085)
10. Mouly-Bertin C, Bissery A, Milon H, Dzudie A, Rabilloud M, Bricca G, Vincent M, Lantelme P. N-terminal pro-brain natriuretic peptide: a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women. Arch Cardiovasc Dis. 2008;101:307-315.
11. Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlof B, Hildebrandt PR. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than highsensitivity C-reactive protein in hypertension: a LIFE substudy. J Hypertens. 2006;24:1531-1539. (Pubitemid 44162454)
12. Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H, Rokkedal J, Devereux RB, Hildebrandt P. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. J Hypertens. 2004;22: 1597-1604. (Pubitemid 39037612)
13. Pedersen F, Raymond I, Kistorp C, Sandgaard N, Jacobsen P, Hildebrandt P. N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events. J Card Fail. 2005; 11:S70-S75.
14. Lantelme P, Rohrwasser A, Vincent M, Cheng T, Gardier S, Legedz L, Bricca G, Lalouel JM, Milon H. Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status. J Hypertens. 2005;23:785-792. (Pubitemid 40523277)
15. Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail. 2004;6:365-368. (Pubitemid 38253059)
16. Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Repaci S, Pede S, Borgioni C, Gentile G, Reboldi G. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. J Hypertens. 2009;27:1697-1704.
17. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34: 618-620. (Pubitemid 29436163)
18. Abacherli R, Zhou L, Schmid JJ, Kobza R, Niggli B, Frey F, Erne P. Correlation relationship assessment between left ventricular hypertrophy voltage criteria and body mass index in 41,806 Swiss conscripts. Ann Noninvasive Electrocardiol. 2009;14:381-388.
19. Morillas P, Castillo J, Quiles J, Nunez D, Guillen S, Maceira A, Rivera M, Bertomeu V. Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients: a cardiac magnetic resonance study. Rev Esp Cardiol. 2008;61:972-975.
20. Conen D, Zeller A, Pfisterer M, Martina B. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol. 2006;97:249-252. (Pubitemid 43139245)
21. Julien J, Tranche C, Souchet T. Left ventricular hypertrophy in hypertensive patients: epidemiology and prognosis [in French]. Arch Mal Coeur Vaiss. 2004;97:221-227. (Pubitemid 38428775)
22. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992;92:29-34.
23. Belluardo P, Cataliotti A, Bonaiuto L, Giuffre E, Maugeri E, Noto P, Orlando G, Raspa G, Piazza B, Babuin L, Chen HH, Martin FL, McKie PM, Heublein DM, Burnett JC Jr, Malatino LS. Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2006;291:H1529-H1535. (Pubitemid 44497655)
24. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996;28:988-994. (Pubitemid 26415815)
25. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta. 2004;341: 41-48. (Pubitemid 38210312)
26. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis: II-accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503-1510. (Pubitemid 26035533)
27. McKie PM, Rodeheffer RJ, Cataliotti A, Martin FL, Urban LH, Mahoney DW, Jacobsen SJ, Redfield MM, Burnett JC Jr. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension. 2006; 47:874-880. (Pubitemid 44297558)
28. Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, Breteler MM, Witteman JC, van den Meiracker AH. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam Study. Hypertension. 2010;55:785-791.
29. Tschope C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J. 2005;26:2277-2284. (Pubitemid 41541392)
30. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul Study. Circulation. 2003;108: 2987-2992. (Pubitemid 37553567)
31. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655-663. (Pubitemid 38364624)
32. Yambe M, Tomiyama H, Koji Y, Motobe K, Shiina K, Gulnisia Z, Yamamoto Y, Yamashina A. B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens. 2006;19:443-447.
33. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation. 2004;109:3176-3181.
34. Johnston N, Jernberg T, Lindahl B, Lindback J, Stridsberg M, Larsson A, Venge P, Wallentin L. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem. 2004;37: 210-216. (Pubitemid 38221569)
35. Troughton RW, Richards AM, Yandle TG, Frampton CM, Nicholls MG. The effects of medications on circulating levels of cardiac natriuretic peptides. Ann Med. 2007;39:242-260. (Pubitemid 46897664)